FS

Florian Sennlaub

CN CNRS: 4 patents #613 of 11,908Top 6%
SU Sorbonne Universite: 4 patents #11 of 655Top 2%
VP Valorisation-Recherche, Limited Partnership: 3 patents #10 of 112Top 9%
VP Valorisation Hsj, Limited Partnership: 3 patents #1 of 36Top 3%
IT Institut Pasteur De Tunis: 1 patents #5 of 15Top 35%
U6 Universite Pierre Et Marie Curie (Paris 6): 1 patents #140 of 554Top 30%
Overall (All Time): #502,707 of 4,157,543Top 15%
10
Patents All Time

Issued Patents All Time

Showing 1–10 of 10 patents

Patent #TitleCo-InventorsDate
11191807 Lebecetin, a C-type lectin, as neovascularization inhibitor Xavier Guillonneau, Fadoua Montassar, Naziha Marrakchi, Erij Messadi, Jose-Alain Sahel 2021-12-07
11142548 Agents that activate CD47 and their use in the treatment of inflammation Michael Housset, Xavier Guillonneau, Jose-Alain Sahel, Philippe Karoyan 2021-10-12
11072661 Agents that inhibit the binding of CFH to CD11 b/CD18 and uses thereof Bertrand Callippe, Xavier Guillonneau, Jose-Alain Sahel 2021-07-27
10519232 Agents for use in the treatment of retinal inflammation Xavier Guillonneau, Olivier Levy, Jose-Alain Sahel 2019-12-31
10253087 CCR2 antagonist peptides Christophe Combadiere, Constance Auvynet, Sylvian Chemtob, Christiane Quiniou 2019-04-09
9708370 Azapeptides as CD36 binding compounds Huy Ong, Sylvain Chemtob, William Lubell, Damien Boeglin, Caroline Proulx +2 more 2017-07-18
9434766 CCR2 antagonist peptides Christophe Combadiere, Constance Auvynet, Sylvian Chemtob, Christiane Quiniou 2016-09-06
9115171 Azapeptides as CD36 binding compounds Huy Ong, Sylvain Chemtob, William Lubell, Damien Boeglin, Caroline Proulx +2 more 2015-08-25
8603964 Methods for modulating angiogenesis via dystrophin Dp71 Romain Bernard, Bénédicte Dupas, Alain Gaudric, Serge Picaud, Alvaro Rendon +4 more 2013-12-10
8435954 Azapeptides as CD36 binding compounds Huy Ong, Sylvain Chemtob, William Lubell, Damien Boeglin, Caroline Proulx +2 more 2013-05-07